Objective:To investigate endoscopic treatment and its effects on non-varicose upper gastrointestinal bleeding in elderly patients.Methods:From June 2018 to September 2019, 86 elderly patients with non-varicose upper gastrointestinal bleeding treated in our hospital were enrolled and underwent endoscopic hemostasis.They were divided into the observation group(n=45, receiving endoscopic hemostasis combined with somatostatin treatment)and the control group(n=41, only receiving endoscopic hemostasis treatment). Clinical effects were evaluated in the two groups.Results:The immediate hemostasis rate was higher and the rebleeding rate within 1 week was lower in the observation group than in the control group(95.6% or 43/45 vs.80.5% or 33/41, 11.1% or 5/45 vs.29.3% or 12/41, χ2=4.740 and 4.460, P=0.030 and 0.035). Arrhythmias, multiple organ failure, and death during treatment occurred in 1 case, 0 cases, and 0 cases in the observation group and 4 cases, 2 cases, and 1 case in the control group, respectively.The incidence of complications was lower in the observation group than in the control group(2.2% or 1/45 vs.17.1% or 7/41, χ2=5.608, P=0.018). Conclusions:Endoscopic hemostasis combined with somatostatin treatment can not only achieve satisfactory hemostatic effects, but also reduce the incidence of rebleeding in elderly patients with non-varicose upper gastrointestinal hemorrhage, and thus plays an important role in alleviating suffering and ensuring safety in elderly patients.

Objective: To investigate the delayed effect of liver injury and metabolism of dimethylformamide (DMF) after high exposures in rats. Methods: A total of 12 rats were randomly divided into four groups and 3 rats were in each group. Rats in 1d DMF+2 d delayed group were dosed for 1 day and rested for 2 days, and sacrificed at the 4th day. Rats in 3 d DMF group were dosed for 3 days and sacrificed at the 4th day. Rats in 3 d DMF+3 d delayed group were dosed for 3 days and rested for 3 days, and sacrificed at the 7th day. Rats in control group were administrated with water for 3 days, sacrificed at the 7th day. The administrated dose was 1 000 mg/kg (body weight·d) DMF by oral. The daily observation and body weight were recorded during the study period. After the experiment, the blood biochemistry, including alanine aminotransferase (ALT) , aspartate aminotransferase (AST) , lactic dehydrogenase (LDH) , alkaline phosphatase (ALP) , total bilirubin (TBIL) etc. were detected. Liver weight, kidney weight, liver/body ratio, kidney/body ratio and pathologic examination of liver and kidney were investigated. The concentrations of hemoglobin-adduct (NMHb) were detected. Results: During the period of 1~3 d, body weight growth rate of rats in each treated group had no significant difference with control rats. In the 4~6 th day of the period, rats in group 3 became thinner than before, and the body weight was negative growth (-4.22±3.29 g/d) and significant lower than that of control rats (10.33±3.21 g/d, F=30.07, P<0.05) . AST and LDH levels of 3 d DMF group were significant higher than control group (P<0.05) . Liver/body ratio in 3 d DMF+3 d delayed group were significant higher than control group (P<0.05) . The gross inspection showed 1 rat and 3 rats were observed liver injury in 3 d DMF group and 3 d DMF+3 d delayed group, respectively. Histopathological lesions of 1d DMF+2 d delayed group, 3 d DMF group and 3 d DMF+3 d delayed group were mainly spotty necrosis, focal necrosis and large necrosis of liver cells, respectively. Only NMHb level of control group was undetectable. NMHb levels in 3 d DMF+3 d delayed group were significantly higher than 3 d DMF group (F=135.46, P<0.05) . Conclusion The DMF-induced liver injury and DMF metabolism may be delayed after high DMF exposures in rats.

Objective To observe the value of multimodal imaging for diagnosis of cardiac space-occupying lesions.Methods Data of 70 patients with cardiac space-occupying lesions who underwent echocardiography and cardiac CT(CCT)were retrospectively analyzed,among them 35 also underwent cardiac MRI(CMRI).The value of multimodal imaging for diagnosis of cardiac space-occupying lesions were explored according to the results of surgical pathology or clinical diagnosis.Results Among 70 cases,benign tumors were confirmed by surgical pathology in 43 cases,while malignant tumors were confirmed by surgical pathology in 3 cases and clinically diagnosed in 1 case.Meanwhile,non-tumor-occupying lesions were clinically diagnosed in 23 cases,all obviously shrunken after treatments.Among 70 cases,echocardiography correctly diagnosed 57 cases,misdiagnosed 8 cases and unclearly diagnosed 5 cases,with diagnostic accuracy rate of 81.43%(57/70).CCT correctly diagnosed 63 cases,misdiagnosed 4 cases but missed 3 cases,with diagnostic accuracy rate of 90.00%(63/70).CMRI outcomes in all 35 cases were consistent with surgical pathologic results,with diagnostic accuracy rate of 100%(35/35).Conclusion Multimodal imaging might provide objective evidences for diagnosis and treatment of cardiac space-occupying lesions.